all report title image
  • Published In : Mar 2023
  • Code : CMI5586
  • Pages : 172
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
Ingographics Image

Analgesics are medicines that are used to relieve pain. They are also known as painkillers or pain relievers. These are a class of medicines designed specifically to relieve pain. They include several classes of drugs (such as non-steroidal anti-inflammatory drugs, acetaminophen, antiepileptics, antidepressants, opioids, and local anesthetics).  

Market Dynamics:

Rise in prevalence chronic diseases, increase in adoption of OTC analgesics or rise in consumption of OTC analgesics, rise in geriatric population, and rise in demand for narcotics analgesic drugs are major factors expected to drive growth of the global over the counter (OTC) analgesics market.

For instance, in December 2021, Heron Therapeutics, Inc. announced that the U.S. Food & Drug Administration (FDA) approved its supplemental New Drug Application (sNDA) for ZYNRELEF (bupivacaine and meloxicam) extended-release solution to significantly expand the indication.

Moreover, in July 2021, Heron Therapeutics announced the commercial launch and availability of ZYNRELEF in the U.S. for the management of postoperative pain for up to 72 hours.

Key features of the study:

  • This report provides in-depth analysis of the over the counter (OTC) analgesics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global over the counter (OTC) analgesics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Sanofi SA, Reckitt Benckiser Group PLC, Pfizer Inc., Mylan NV, GlaxoSmithKline PLC, Johnson & Johnson, Bayer, Takeda Pharmaceutical, and Sun Pharmaceutical Industries Ltd., among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global over the counter (OTC) analgesics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global over the counter (OTC) analgesics market.

Detailed Segmentation:

  • Global Over the Counter (OTC) Analgesics Market, By Type of Drug:
    • Acetaminophen
    • Nonsteroidal Anti- inflammatory Drug (NSAIDs)
    • Salicylates
    • Other Analgesics
  • Global Over the Counter (OTC) Analgesics Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Others Distribution Channels
  • Global Over the Counter (OTC) Analgesics Market, By Geography:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles:
    • Sanofi SA
    • Reckitt Benckiser Group PLC
    • Pfizer Inc.
    • Mylan NV
    • GlaxoSmithKline PLC
    • Johnson & Johnson
    • Bayer AG
    • Takeda Pharmaceutical
    • Sun Pharmaceutical Industries Ltd.

Table of Contents:

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Type of Drug
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Geography
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • High prevalence chronic diseases and rise in geriatric population
      • Drug tolerance, dependence, and addiction and abuse
      • Increase in adoption or rise in consumption of OTC analgesics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product launch/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Global Over the Counter (OTC) Analgesics Market – Impact of Coronavirus (COVID-19) Pandemic
    • COVID-19 Epidemiology
    • Supply Side and Demand Side Analysis
    • Economic Impact
  5. Global Over the Counter (OTC) Analgesics Market, By Type of Drug, 2023-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 – 2030
      • Segment Trends
    • Acetaminophen
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
    • Nonsteroidal Anti-Inflammatory Drug (NSAIDs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
    • Salicylates
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
    • Other Analgesics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  6. Global Over the Counter (OTC) Analgesics Market, By Distribution Channel, 2023-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 – 2030
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
    • Others Distribution Channels
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  7. Global Over the Counter (OTC) Analgesics Market, By Geography, 2023-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 – 2030
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
    • Middle East and Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
  8. Competitive Landscape
    • Sanofi SA
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Reckitt Benckiser Group PLC
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Mylan NV
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GlaxoSmithKline PLC
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Johnson & Johnson
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bayer AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Takeda Pharmaceutical
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sun Pharmaceutical Industries Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Analyst Views
  9. Section
    • Research Methodology
    • About us

*Browse 24 market data tables and 28 figures on "Global Over the Counter (OTC) Analgesics Market” - forecast to 2030

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

Esomar
Duns
Clutch
DMCA

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo